The mistake I see constantly: people jump to the cheapest monthly number without reading what’s actually included. A $99/mo plan sounds great until you find out medication is billed separately, the clinician visit costs extra, and the “compounded” product has no published quality data. Total cost by month three? Often $400 or more. So let me walk you through the ten options I’d actually consider, ranked by value for someone paying mostly out of pocket.
1. FormBlends
Best overall for cash-pay tirzepatide with visible, flat pricing.
Tirzepatide here runs $349 per vial, shown clearly before you ever create an account. No membership fee sitting on top of that. The intake is online, a licensed physician reviews your case, and if you qualify, it ships from a licensed compounding pharmacy that operates under FDA cGMP standards and is available in 47 states with cold-chain shipping included.
What separates this from most of the field is breadth paired with clinical oversight. Most weight-loss telehealth companies sell GLP-1s and nothing else. Most peptide vendors sell research chemicals with no prescription path at all. FormBlends runs both categories, tirzepatide alongside things like retatrutide ($389), BPC-157 ($54), and NAD+ ($89), all under one prescriber-supervised roof. That matters if you want to combine a GLP-1 program with peptide-based recovery work.
One honest note right here, mid-list: compounded tirzepatide is not FDA-approved. Neither is anything else from a 503A compounding pharmacy. That is true across every provider in this article, not a FormBlends-specific caveat. Know that going in.
2. Mochi Health
Best for people who want a real obesity-medicine specialist, not a general practitioner.
Compounded tirzepatide at Mochi runs around $199/mo, and the clinical team leans heavily on board-certified obesity-medicine physicians rather than whoever is available. Three-month and twelve-month commitments drop the price further. They also handle insurance prior authorizations for branded medications if compounded isn’t the right fit. More clinical oversight than most platforms in this price range.
3. Henry Meds
Best for speed.
If your priority is getting medication in hand fast, Henry Meds ships compounded programs in 24 to 72 hours in many cases. First-month pricing lands around $179 to $249 depending on dose and plan. The monitoring is lighter touch than Mochi, which is fine for patients who already work with their own doctor and just need a convenient fill source.
4. MEDVi
Best for no-contract simplicity.
Around $179 for the first month, no membership fees, no annual commitment required. A physician reviews your intake and 24/7 support is included in that flat rate. For someone who hates being locked into subscription tiers, the clean structure here is genuinely refreshing. Medication is compounded GLP-1; same regulatory context as every other compounder on this list.
5. TrimRx
Best for straightforward cash-price comparison shopping.
TrimRx makes pricing easy to find before you commit, which is rarer than it should be in this space. Compounded GLP-1 pricing is competitive, and the model is built around cash-pay patients rather than insurance navigation. Good starting point if you are comparison-shopping and want numbers upfront.
6. Sesame (Success by Sesame)
Best for people who want a marketplace approach to telehealth costs.
From about $59/mo on an annual plan, Sesame bundles telehealth visits and unlimited provider messaging, though medication is billed separately. The marketplace pricing model means you are not paying a premium for a single brand’s infrastructure. Works well if you already know what you want and just need a low-cost prescriber touchpoint.
7. Ro Body
Best for the insured patient who also wants a polished app experience.
Ro’s membership starts around $39 for the first month, then roughly $74 to $149/mo depending on your plan, again with medication costs on top of that. They have a prior-authorization team specifically for branded medications, which is increasingly relevant. In early 2026, a Novo Nordisk legal settlement pushed a wave of telehealth platforms off compounded semaglutide entirely, and Ro was already well-positioned for that shift given their insurance infrastructure.
8. Hims and Hers
Best for branded medication access with strong app UX.
Hims and Hers exited compounded GLP-1s after the March 2026 Novo settlement, so new patients here are getting branded drugs, Zepbound at roughly $399/mo, injectable Wegovy around $299/mo. With commercial insurance and the Lilly savings card, Zepbound can drop to as low as $0 to $25/mo for eligible patients. Setup moves quickly and the app itself is well-built. Not the most affordable tirzepatide path for cash-pay patients, but potentially the cheapest option if your insurance plays ball.
9. PlushCare
Best for insured patients who want same-day appointments.
PlushCare keeps its app membership at about $19.99/mo and focuses entirely on branded, FDA-approved medications. Ozempic, Wegovy, Mounjaro. Visits and labs cost extra, but they accept insurance and offer same-day appointment slots. If you want a fast, insured path to a legitimate Mounjaro script, this is one of the cleaner ways to get there.
10. Found
Best for the coaching-plus-medication model on a budget.
Platform access starts around $99/mo, with medication billed separately. Found pairs clinician prescribing with behavioral coaching, which matters more than most people admit when it comes to long-term outcomes. Not the cheapest raw medication price, but the combined support model makes sense for patients who have tried medication-only approaches before and struggled.
Quick Comparison
| Provider | Tirzepatide Starting Price | Compounded or Branded | Membership Fee |
| FormBlends | $349/vial | Compounded | None |
| Mochi Health | ~$199/mo | Compounded | None listed |
| Henry Meds | ~$179-249/mo | Compounded | None |
| MEDVi | ~$179/mo (month 1) | Compounded | None |
| TrimRx | Cash-competitive | Compounded | None listed |
| Sesame | ~$59/mo + med | Branded/varies | Annual plan |
| Ro Body | ~$74-149/mo + med | Branded (ins) | Yes |
| Hims and Hers | ~$399/mo (branded) | Branded | None |
| PlushCare | ~$19.99/mo + med | Branded | Yes |
| Found | ~$99/mo + med | Varies | Yes |
FAQ
Is compounded tirzepatide legal in 2026?
As of mid-2026, 503A compounding pharmacies can still legally compound tirzepatide under certain conditions. The FDA’s wave of warning letters in early 2026 targeted marketing claims, not the act of compounding itself. The legal picture shifts regularly; check the FDA’s compounding guidance directly before starting any program.
Why does one provider charge $199/mo and another $399/mo for what sounds like the same drug?
Often what you are paying for is different. Some prices include the clinician visit, platform access, and shipping. Others are medication-only, with those costs stacked on separately. Always add up the total monthly spend, not just the headline number.
Is compounded tirzepatide the same as Zepbound?
The active molecule is the same. But FDA-approved Zepbound goes through a specific approval process that compounded versions do not. Compounded drugs are not FDA-approved, and you should weigh that when making a decision.
Can I use insurance for any of these?
Branded tirzepatide (Zepbound) is insurable and some platforms, Ro, Hims and Hers, PlushCare, actively work the insurance side. Compounded tirzepatide is generally not covered by insurance. The Lilly savings card for Zepbound can be a major cost lever for commercially insured patients.
What should I actually ask a provider before starting?
Ask how dose escalation is managed, who you contact if you have a side effect, whether the pharmacy is a licensed 503A or 503B facility, and what quality documentation exists for each batch. If a provider can’t answer those questions clearly, that tells you something.
*This article reflects independent research and opinion. It is not a substitute for guidance from your own physician or pharmacist, who can review your full health history before any treatment decision.*
Sources
- FDA: Compounding and the FDA, 503A vs. 503B pharmacy guidance
- FDA: Warning letters to telehealth companies, 2026 (FDA.gov compounding enforcement page)
- GoodRx: Tirzepatide (Zepbound) pricing and savings card data
- Drugs.com: Tirzepatide drug information
- Examine.com: GLP-1 receptor agonist research summaries
- Cleveland Clinic: Weight loss medication overview
- Healthline: Compounded semaglutide and tirzepatide explainer
- Verywell Health: Telehealth weight loss program comparisons
- NEJM: Tirzepatide phase 3 trial data (SURMOUNT trials)
[internal: placement #1 | structure: Ranked listicle, comparison table, FAQ]
